*Corresponding Author:
Laxmi Goswami
Department of Pharmacy, G. R. D. Institute of Management and Technology, 214-Rajpur Road, Dehradun-248 009
E-mail: [email protected]
Date of Submission 7 September 2009
Date of Revision 8 March 2010
Date of Acceptance 4 August 2010
Indian J Pharm Sci,2010, 72 (4): 507-510  

Abstract

This work deals with the simultaneous estimation of metformin hydrochloride and pioglitazone hydrochloride in a bilayered tablet dosage form, without prior separation by two techniques. The methods employed are derivative spectrophotometery and Q analysis. The absorption maxima at 231 nm and 269 nm were used for the estimation of metformin and pioglitazone, respectively. Both the drugs and their mixture obey Beer-Lamberts law at selected wavelength at given concentration range. The result of analysis has been validated statistically and recovery studies confi rmed the accuracy of the proposed method. The proposed procedures are simple, rapid, require no separation steps and can be used for the routine analysis of both drugs.

Keywords

Derivative spectrophotometery, metformin, pioglitazone, q-analysis, simultaneous equation method

Introduction

Combined tablets of metformin and pioglitazone hydrochloride are available containing 500 mg of metformin and 15 mg of pioglitazone hydrochloride. Because metformin’s insulin-sensitizing effect occurs mainly at the liver, combination with thiazolidinediones (TZDs), which mainly sensitize muscle to insulin-mediated glucose uptake, is a rational therapeutic strategy [1].

The aim of this paper was to explore the possibility of using techniques of absorbance ratio or Q-analysis method and derivative spectrophotometery methods for quantifying metformin and pioglitazone simultaneously in their mixture form. The advantage of these proposed methods is that no separation is required. The proposed procedures are simple, rapid and act as convenient alternative to HPLC method [2].

The absorption spectra of the reference and test solutions were recorded over the range of 200-400 nm keeping the solutions in 1 cm quartz cells using Shimadzu UV/Vis double beam spectrophotometer model 1700 Pharmaspec.

Gift samples of pure metformin and pioglitazone hydrochloride were procured from Zydus Cadila, Sikkim. Combined metformin and pioglitazone tablets (Pioz*MF-15 containing metformin-500 mg and pioglitazone-15 mg and manufactured by USV Limited) were purchased from a local pharmacy. Analytical reagent grade hydrochloric acid, N,Ndimethyl formamide, distilled water was used as solvent. Stock solutions (500 μg/ml) of metformin and pioglitazone hydrochloride were prepared by dissolving separately 50 mg in 10 ml of N,Ndimethyl formamide in 100 ml volumetric flasks, and the volume was made up to 100 ml with 0.1 N hydrochloric acid.

In the quantitative assay of two components by Q-analysis method [3], absorbance were measured at two wavelengths, one being the isoabsorptive point and other being the wavelength of maximum absorption of one of the two components. From the overlain spectra of metformin and pioglitazone, 247.5 nm was the isoabsorptive point for both the drugs and other at 231 nm, the λmax for metformin was selected (fig. 1). The method employs Q-values, concentrations of drugs in sample solutions were determined using equation C1= (Q0–Q2)/(Q1–Q2)×(A/ a1) for pioglitazone and C2= (Q0–Q2)/(Q2–Q1)×(A/ a2) for metformin, where Q0= absorption of sample at 231 nm/absorption of sample at 247.5 nm, Q1= absorptivity of pioglitazone at 231 nm/absorptivity of pioglitazone at 247.5 nm, Q2= absorptivity of metformin at 231 nm/absorptivity of metformin at 247.5 nm, A= absorption of sample at isoabsorptive point and a1 and a2= absorptivities of pioglitazone and metformin respectively at isoabsorptive point.

Figure

Fig. 1: Overlain Spectra of metformin and pioglitazone

In the derivative spectrophotometery [4] method solutions of 10 μg/ml of metformin and pioglitazone were prepared separately. Both the solutions were scanned in the spectrum mode from 400 to 200 nm. The absorption spectra thus obtained were derivatized from first to fourth order. First order derivative was selected for analysis of both the drugs. The zero crossing wavelengths, 269 and 231 nm were selected for pioglitazone and metformin respectively (fig. 2).

Figure

Fig. 2: Derivative spectrophotometry of metformin and pioglitazone

For preparation of calibration curves five mixed standards having concentrations 0.5, 1, 1.5, 3 and 4.5 μg/ml of pioglitazone and 16.5, 33, 50, 100 and 150 μg/ml of metformin, respectively were prepared and scanned in the spectrum mode from 400 to 200 nm. The absorption spectra so obtained were derivatized to obtain first derivative order spectra. The absorbance of pioglitazone and metformin were measured at 269 and 231 nm, respectively and working calibration curves of both the drugs were plotted separately.

The concentration of individual drug present in the mixture was determined against calibration curve in quantitation mode.

Twenty tablets were weighed accurately. The average weight was determined and then ground to a fine powder. A quantity equivalent to 15 mg of pioglitazone and 500 mg of metformin were transferred to a 100 ml volumetric flask. The contents were ultrasonicated for 10 min with solvent, made to volume and filtered through Whatmann filter paper. The solution was further diluted with solvent, to give concentration of μg/ml of pioglitazone and metformin, respectively. Absorbance of these solutions was measured at 269 nm and 231 nm, and concentration of pioglitazone and metformin obtained from standard calibration curve. Results of tablet analysis of the tablet formulation are reported in Table 1. Accuracy, reproducibility and precision of the proposed method were studied with the help of recovery studies that was carried out by addition of standard drug solution to pre-analyzed sample.

Method Label Claim (mg/tablet) Percent found (±SD)  
  Pio Met Pio Met
DS 15 500 99.13±0.978 99.90±0.637
QA 15 500 99.53±1.084 99.92±0.714

Table 1: Analysis Of Tablet Formulation

The proposed methods for simultaneous estimation of pioglitazone and metformin dosage forms were found to be simple, accurate, economical and rapid. In both the methods, the values of coefficient of variation were satisfactorily low and recovery was close to 100% (Table 2) for both the drugs. Hence it can be employed for routine analysis in quality control laboratories.

Method   Level of % recovery % Recovery found Standard deviation Standard error
DS QA Pio Met Pio Met Pio Met
80 99.87 100.27 0.554 1.286 0.320 0.743
100 99.85 99.20 0.528 1.311 0.305 0.757
120 99.91 99.47 0.581 1.249 0.337 0.721
80 99.71 99.33 0.140 1.331 0.081 0.768
100 99.85 99.20 0.466 1.587 0.275 0.916
120 99.91 99.47 0.689 1.514 0.408 0.874

Table 2: Recovery Study Data Of Tablet Formulation

Acknowledgements

The authors are thankful to Zydus Cadila for providing gift samples of pioglitazone and metformin.

References